Nanexa, a Swedish pharmaceutical company specializing in long-acting injectables, announced today it has signed a license and option agreement with Moderna. Under the agreement, Moderna receives a license to use Nanexa’s proprietary PharmaShell drug delivery platform with its first selected compound and holds options to obtain licenses for up to four additional compounds. The deal […]

The postModerna partners with Nanexa on drug delivery techappeared first onRolling Out.